Skip to content
MHMS
Menu
  • Home
  • Your Health
    • CONDITIONS & TREATMENTS
      • Asthma
      • Cancer
      • Dengue Fever
      • Diabetes
      • Diarrhoea
      • Genital Warts
      • Gonorrhoea
      • Heart Disease
      • Hepatitis-B
      • HIV/AIDS
      • Leptospirosis
      • Lymphatic Filariasis
      • Lung Disease
      • Meningococcal Disease
      • Meningococcal C Disease Immunization
      • NCDs
      • Obesity
      • RHD
      • Stroke
      • Syphilis
      • S.T.H
      • Sexual Health
      • Trachoma
      • Tuberculosis
      • Typhoid Fever
      • Zika Virus
    • HEALTHY YOU
      • Alcohol
      • Blood Donation
      • Eating Healthy
      • Kava
      • Mental Health
        • Suicide
      • Oral Health
      • Physical Health
      • Quit Smoking
      • Stay Hydrated
      • Vegetarian
    • HEALTHY KIDS
      • Breastfeeding
      • Childhood Obesity
      • Hepatitis B
      • Immunisation
      • Micronutrients
      • Malnutrition
      • Rheumatic Heart Disease
    • OTHER
      • Flooding
  • Health Services
    • Wellness Fiji
    • Family Health
    • Health Protection
    • Dietetics and Nutrition
    • Oral Health
    • National Health Disaster and Emergency Management Unit
    • Research, Innovation, Data Analysis & Management
      • Fiji Health Research Portal
    • Fiji Pharmaceutical & Biomedical Services Centre (FPBS)
      • Fiji’s National Action Plan on Antimicrobial Resistance 2022-2025
      • Fiji Medicines Regulatory Authority
      • Free Medicine Scheme
  • Media
    • Board of Visitors Resources
    • Publications
    • Tenders
    • PRESS RELEASE
    • SPEECHES
    • Health Emergency & Disaster Management
    • PHOTO GALLERY
    • VIDEO GALLERY
    • Site Archives
      • Health Updates
      • HEALTH ARTICLES
  • Vacancies
  • Know Us
    • Our Work
    • Contact Us
    • About Us
  • COVID-19
    • PRESS RELEASE
    • Antigen Testing
    • VACCINATION
      • Registration
      • Vaccine FAQs
      • Vaccine Resources
    • COVID-19 FAQs
    • World Bank Project
  • LTDs
Menu

COVID-19 Vaccination Program

Posted on March 3, 2022 by Publishing Team

Last Updated on 2 years by Publishing Team

2nd March 2022
Public Advisory

Individuals who are currently receiving the first and second dose of the COVID-19 vaccines will be administered with the Pfizer COVID-19 vaccine. The Ministry of Health and Medical Services reminds the public that currently there are no stocks of AstraZeneca vaccine in the country therefore, Pfizer is offered for primary series.

Additionally, both, Pfizer and Moderna COVID-19 vaccines are administered as booster doses to individuals aged 18 years and above. Individuals become eligible for the booster dose 5 months after they have received their 2nd dose.
Eligible individuals are encouraged to get their booster doses to maintain maximum and longer-lasting protection against severe consequences from COVID-19.

Search

PE Recent Posts

  • Update: DIARRHEA OUTBREAK IN BALEVUTO
    MINISTRY OF HEALTH AND MEDICAL SERV...
  • DIARRHEA OUTBREAK IN BALEVUTO, BA
    MINISTRY OF HEALTH AND MEDICAL SERV...
  • The rumored strike/protest by the nurses is not happening
    PRESS RELEASE 23 AUGUST 2023  ...
  • COVID-19 Update 29-06-2023
    COVID-19 Update Thursday 29th June ...
  • COVID-19 Update 15-06-2023
    COVID-19 Update Thursday 15th June ...

  • COVID-19 Updates
  • COVID-19 Resources
  • Vaccination Campaign
  • Vaccine Registration
  • Vaccine FAQs
  • Entry Conditions into Fiji
  • Traveling to Fiji
  • Fiji Airways Vaccination Policy

Partners in Health

  • MINISTRY OF COMMERCE, TRADE, TOURISM & TRANSPORT
  • WHO – Western Pacific
  • The Pacific Community
  • UNICEF
©2023 MHMS | Design: Newspaperly WordPress Theme